David Kraus, MD
Interventional Cardiology · Germantown, TNNPI 1225015712
Payments from drug & device makers
Across 580 payments — averaging $347.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$110K
- Boston Scientific$43K
- Bayer$32K
- Novartis$5K
- Alnylam Pharmaceuticals Inc.$5K
- Amgen$1K
- plus $6K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 127 | $110,345 |
| Boston Scientific | 11 | $42,900 |
| Bayer | 19 | $31,586 |
| Novartis | 91 | $5,042 |
| Alnylam Pharmaceuticals Inc. | 23 | $4,688 |
| Amgen | 48 | $1,109 |
| Pfizer | 41 | $725 |
| Abbott | 24 | $682 |
| Boehringer Ingelheim | 30 | $496 |
| E.r. Squibb & Sons, L.L.C. | 19 | $476 |
| Akcea Therapeutics, Inc. | 6 | $396 |
| AstraZeneca | 21 | $334 |
| Novo Nordisk | 14 | $317 |
| Johnson & Johnson | 23 | $314 |
| Bridgebio Pharma, Inc. | 9 | $228 |
| Philips North America LLC | 10 | $225 |
| Sanofi-aventis U.S. LLC | 12 | $201 |
| Biotronik Inc. | 4 | $197 |
| Impulse Dynamics (USA) Inc. | 3 | $184 |
| Regeneron Healthcare Solutions, Inc. | 9 | $163 |
| Lundbeck LLC | 6 | $115 |
| Arbor Pharmaceuticals, Inc. | 5 | $89 |
| Esperion Therapeutics, Inc. | 4 | $75 |
| Lexicon Pharmaceuticals, Inc. | 4 | $68 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $43 |
| Portola Pharmaceuticals, LLC | 2 | $40 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Daxor Corporation | 1 | $23 |
| United Therapeutics Corporation | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
How this compares
$201,259 in reported general payments places this provider in the 90th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Germantown
- Mehul PatelGermantown$810K
- Basil PaulusGermantown$768K
- James KlemisGermantown$31K
- Justin MayGermantown$23K
- Tamunoinemi Bob-ManuelGermantown$22K
- Michael MorseNashville$3.5M
- Charles TreasurePowell$3M
- Colin BarkerNashville$2.1M
- Brian JeffersonNashville$2.1M
- Malcolm FosterKnoxville$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.